I would just say that this thing provides an opportunity once in a decade kind of situation where we should look at it in the perspective that this could be the worst and worst is probably behind.
Former AstraZeneca MD, Gagandeep Singh joins Boehringer Ingelheim Managing Director and Head of Human Pharma for India financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
So, we have seen same thing happening in Accenture for the last two-three quarters and their commentary yesterday was also in similar lines that clients are cutting down the small deals because those are the ones which are short term and which are primarily discretionary and could be probably immediate and avoided if there is a confusion or if there is a cautiousness.
Kanpur : The Startup Incubation and Innovation Centre (SIIC), the technology business incubator of the Indian Institute of Technology Kanpur (IITK), has signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim India, a leading global phar